Alkermes
ALKS
#3000
Rank
NZ$9.22 B
Marketcap
NZ$55.85
Share price
3.73%
Change (1 day)
-9.95%
Change (1 year)

P/E ratio for Alkermes (ALKS)

P/E ratio as of February 2026 (TTM): 16.1

According to Alkermes's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 16.1304. At the end of 2024 the company had a P/E ratio of 12.9.

P/E ratio history for Alkermes from 2001 to 2025

PE ratio at the end of each year

Year P/E ratio Change
202412.9-0.04%
202312.9-147.4%
2022-27.2-64.89%
2021-77.5172.37%
2020-28.575.82%
2019-16.2
2017-53.130.98%
2016-40.6-22.32%
2015-52.2-82.16%
2014-293

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
Johnson & Johnson
JNJ
22.1 37.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
22.7 40.76%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
20.0 23.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
22.9 42.02%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
20.7 28.58%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
38.6 139.42%๐Ÿ‡ฌ๐Ÿ‡ง UK
Zogenix
ZGNX
-6.56-140.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
-0.0676-100.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
27.4 69.59%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.